Xenetic Biosciences, Inc. | Business Contracts

Statement of Work, dated June 30, 2022, between Xenetic Biosciences, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on August 11, 2022)

Form of Subscription Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)

Exclusive License Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)

Second Work Order to Master Service Agreement, dated October 12, 2021, between the Company and PJSC Pharmsynthez (Filed With SEC on March 22, 2022)

Exclusive Sublicense Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)

Amendment Number One to the Master Services Agreement, dated October 12, 2021, between the Company and PJSC Pharmsynthez (Filed With SEC on March 22, 2022)

Exclusive License Agreement, dated December 20, 2021, between Lipoxen Technologies Limited and Public Joint-Stock Company Pharmsynthez (Filed With SEC on March 22, 2022)

Novation of Agreement on Co-Development and the Terms of Exclusive License, dated December 17, 2021, between Xenetic Biosciences (UK) Limited (formerly Lipoxen plc), Lipoxen... (Filed With SEC on March 22, 2022)

At The Market Offering Agreement by and between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated November 19, 2021 (Filed With SEC on November 19, 2021)

Form of Letter Agreement by and between Xenetic Biosciences, Inc. and the Holders, dated November 15, 2021 (Filed With SEC on November 16, 2021)

Form of Series B Warrant (Filed With SEC on July 28, 2021)

Form of Series A Warrant (Filed With SEC on July 28, 2021)

Form of Registration Rights Agreement, dated July 26, 2021, by and among the Company and the other parties thereto (Filed With SEC on July 28, 2021)

Form of Securities Purchase Agreement, dated July 26, 2021, by and among the Company and the other parties thereto (Filed With SEC on July 28, 2021)

Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of July 25, 2021 (Filed With SEC on July 28, 2021)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2021)

Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of December 9, 2020 (Filed With SEC on December 14, 2020)

Form of Securities Purchase Agreement between Xenetic Biosciences, Inc. and the purchasers named therein, dated as of December 10, 2020 (Filed With SEC on December 14, 2020)

Work Order to Master Service Agreement, dated June 12, 2020, between the Company and PJSC Pharmsynthez (Filed With SEC on August 12, 2020)

Master Service Agreement, dated June 12, 2020, between the Company and PJSC Pharmsynthez (Filed With SEC on August 12, 2020)

Research Funding and Option Agreement, dated May 15, 2020, between the Company and the Scripps Research Institute (Filed With SEC on August 12, 2020)

Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2020)

Xenetic Biosciences, Inc. Stock Option Grant Notice, dated December 4, 2019, between Jeffrey Eisenberg and Xenetic Biosciences, Inc (Filed With SEC on March 26, 2020)

Form of Xenetic Biosciences, Inc. Stock Option Grant Notice (Filed With SEC on March 26, 2020)

Form of Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc (Filed With SEC on March 26, 2020)

Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Grigory G. Borisenko, effective as of September 26, 2019 (Filed With SEC on March 26, 2020)

Underwriting Agreement (Filed With SEC on July 22, 2019)

Warrant Agency Agreement (Filed With SEC on July 22, 2019)

Form of Purchase Warrant (Filed With SEC on July 22, 2019)

Form of Pre-Funded Warrant (Filed With SEC on July 22, 2019)

Consent Agreement (Filed With SEC on July 16, 2019)

Third Amendment to the OPKO Assignment Agreement (Filed With SEC on July 16, 2019)

Third Amendment to the Share Purchase Agreement (Filed With SEC on July 16, 2019)

Form of Purchase Warrant (Filed With SEC on July 12, 2019)

Form of Pre-Funded Warrant (Filed With SEC on July 12, 2019)

Form of Purchase Warrant (Filed With SEC on July 2, 2019)

Form of Underwriting Agreement (Filed With SEC on July 2, 2019)

Form of Warrant (Filed With SEC on June 25, 2019)

CONSENT AGREEMENT (Filed With SEC on June 25, 2019)

Second Amendment to the Share Purchase Agreement (Filed With SEC on June 24, 2019)

Second Amendment to the OPKO Assignment Agreement (Filed With SEC on June 24, 2019)

Form of Pre-Funded Warrant (Filed With SEC on June 24, 2019)

Form of Purchase Warrant (Filed With SEC on June 24, 2019)

First Amendment to the OPKO Assignment Agreement (Filed With SEC on June 13, 2019)

First Amendment to the Share Purchase Agreement (Filed With SEC on June 13, 2019)

OPKO Assignment Agreement (Filed With SEC on May 20, 2019)

Share Purchase Agreement (Filed With SEC on May 13, 2019)

OPKO Assignment Agreement (Filed With SEC on May 13, 2019)

Form of Securities Purchase Agreement (Filed With SEC on March 7, 2019)

Form of Purchase Warrant (Filed With SEC on March 7, 2019)

Form of Pre-Funded Warrant (Filed With SEC on March 7, 2019)

Share Purchase Agreement (Filed With SEC on March 4, 2019)

Voting Agreement Pharmsynthez (Filed With SEC on March 4, 2019)

Voting Agreement Dr. Genkin (Filed With SEC on March 4, 2019)

Voting Agreement OPKO (Filed With SEC on March 4, 2019)

OPKO Assignment Agreement (Filed With SEC on March 4, 2019)

Xenetic Biosciences, Inc. (56)